External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients-Reference-Cited by-同舟云学术

External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients

Published:2017-04-02 Issue:8 Volume:77 Page:928-933
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Beauval Jean-Baptiste¹^ORCID,Cabarrou Bastien²,Gandaglia Giorgio³,Patard Pierre-Marie¹,Ouzzane Adil⁴,de la Taille Alexandre⁵,Soulié Michel¹,Briganti Alberto⁶,Ploussard Guillaume⁷,Rozet François⁸^ORCID,Roumiguié Mathieu¹

Affiliation:

1. Department of Urology; Centre Hospitalier Universitaire de Toulouse; Toulouse France

2. Department of Statistics; Institut Universitaire du Cancer Toulouse Oncopole; Toulouse France

3. Ospedale San Raffaele; Milano Lombardia Italy

4. Centre Hospitalier Regional Universitaire de Lille; Lille France

5. Department of Urology; CHU Mondor; Créteil France

6. Department of Urology; Vita-Salute University San Raffaele; Milan Italy

7. Clinique St Jean du Languedoc; Toulouse France

8. Institut Mutualiste Montsouris; Paris France

Publisher

Wiley

Subject

Urology,Oncology

Reference20 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade;Budaus;BJU Int,2011

3. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update2013;Heidenreich;Eur Urol,2014

4. NCCN clinical practice guidelines in oncology: prostate cancer;Mohler;J Natl Compr Canc Netw,2010

5. Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: implications for active surveillance candidates selection;Gandaglia;Prostate,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral Center;Cancers;2024-06-04

2. Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?;International Urology and Nephrology;2024-03-30

3. The impact of prognostic group classification on prostate cancer progression in intermediate-risk patients according to the European Association of Urology system: results in 479 patients treated with robot-assisted radical prostatectomy at a single tertiary referral center;Therapeutic Advances in Urology;2024-01

4. Improving the Stratification of Patients With Intermediate-risk Prostate Cancer;Clinical Genitourinary Cancer;2021-04

5. Deep Neural Networks Outperform the CAPRA Score in Predicting Biochemical Recurrence After Prostatectomy;Frontiers in Oncology;2021-02-11